Mark Armitage is a Senior Director of Global Government Grants and Contracts at Johnson & Johnson, where they have played a pivotal role in research and development since 2013. With over 25 years in the Pharmaceutical and Healthcare industry, Mark has raised over $4.2 billion in contracts for R&D funding and infrastructure projects, collaborating extensively with government agencies and NGOs on critical health issues. Prior to their current role, Mark served as Business Unit Manager at Crucell, focusing on vaccine platforms, and as Head of Pre-clinical at PowderJect Vaccines. Mark holds a Ph.D. in Cell and Molecular Biology from the University of St Andrews and completed post-doctoral research in HIV Immunology at The University of Edinburgh.
This person is not in the org chart
This person is not in any teams
This person is not in any offices